U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07114562) titled 'Evaluation of the Safety and Performance of Epicare for the Treatment of Periorbital Wrinkles' on Aug. 03.
Brief Summary: This is a prospective, interventional, evaluator-blinded, multi-center study designed to assess the safety and performance of the Epicare device for the treatment of moderate to severe periorbital wrinkles in adults aged 25 to 65 years.
Up to 50 participants will receive a single Epicare laser treatment, with an optional second treatment at Month 2 if clinically indicated. Follow-up visits will occur at Week 1, Month 2, and at 3 or 5 months post-treatment (End of Study), depending on whether one or two treatment...